Mustang | Jotup

ECD Auto Design Electrifies Classic Mustangs, Pioneering EV Vintage Performance

Retrieved on:

星期二, 五月 7, 2024

Range Rover Classic, ECD, Convertible, Defender, Ford Mustang, Finger, Land Rover, Sport, Mustang, EV, Range Rover, Ford, Land Rover Defender, Automotive industry

Following the recent announcement of ECD Auto Design’s product expansion into the American muscle car market, this significant move emphasizes the company's commitment to innovation, sustainability and ultimately customization options.

Key Points:

Following the recent announcement of ECD Auto Design’s product expansion into the American muscle car market, this significant move emphasizes the company's commitment to innovation, sustainability and ultimately customization options.
Each vehicle will exemplify ECD's dedication to pushing the boundaries of automotive design.
In line with ECD's world renown customization model, every classic Mustang will offer a range of powertrain configurations, allowing customers to tailor their vehicles to their preferences.
Elliot Humble, Chief Technology Officer for ECD Auto Design states, “We’re proud to introduce EV technology to our iconic American Mustang models.

Meyers Manx Appoints Two Automotive Industry Veterans to Co-CEO Positions

Retrieved on:

星期三, 五月 8, 2024

Meyers Manx , the original fiberglass dune buggy kit car company founded in 1964 by Bruce Meyers, today announces the appointment of two automotive industry veterans as the company’s co-CEOs.

Key Points:

Meyers Manx , the original fiberglass dune buggy kit car company founded in 1964 by Bruce Meyers, today announces the appointment of two automotive industry veterans as the company’s co-CEOs.
Freeman Thomas, who had been Meyers Manx CEO and Chief Creative Officer, becomes Meyers Manx Vice Chairman.
“Meyers Manx has a rich heritage, and our dune buggies continue to be celebrated by enthusiasts all over the world,” Flake said.
For decades, Meyers Manx has been celebrated for its kit cars, empowering enthusiasts to build their own unique buggies.

Pebblebrook Hotel Trust Reports First Quarter 2024 Results

Retrieved on:

星期二, 四月 23, 2024

Historical and comparable period results of such non-GAAP financial measures have been adjusted to reflect the exclusion.

Key Points:

Historical and comparable period results of such non-GAAP financial measures have been adjusted to reflect the exclusion.
Looking ahead to the rest of 2024, the booking pace for groups remains healthy, particularly in the third and fourth quarters.
A preliminary settlement of $4 million for business interruption proceeds related to income losses in Q3 2023 was recorded in Q1 2024.
Curator Hotel & Resort Collection (“Curator”) is a curated collection of experientially focused small brands and independent lifestyle hotels and resorts worldwide founded by Pebblebrook and several industry-leading independent lifestyle hotel operators.

Standard Motor Products Introduces 268 New Numbers

Retrieved on:

星期二, 四月 23, 2024

NEW YORK, April 23, 2024 /PRNewswire/ -- Standard Motor Products, Inc. (SMP®) has announced the introduction of 268 new part numbers in its April new number announcement. This most recent release provides new coverage in 75 distinct product categories and 80 part numbers for 2023 and 2024 model-year vehicles.

Key Points:

NEW YORK, April 23, 2024 /PRNewswire/ -- Standard Motor Products, Inc. (SMP®) has announced the introduction of 268 new part numbers in its April new number announcement.
This most recent release provides new coverage in 75 distinct product categories and 80 part numbers for 2023 and 2024 model-year vehicles.
Advanced Driver Assistance Systems are becoming increasingly complex, and Standard's high-tech coverage grows to meet demand in these important categories.
Thirteen Park Assist Sensors have been added, offering new coverage for import vehicles including the 2023-20 Toyota Camry and 2022-20 Nissan Rogue.

Ruoyang He Killed in Rear-end Truck Accident in Frisco, TX

Retrieved on:

星期四, 四月 18, 2024

U.S. Route 380, Shoulder, Injury, Mustang, Ford, Road

COLLIN COUNTY, Texas, April 18, 2024 /PRNewswire/ -- Grossman Law Offices, with its principal office in Dallas, TX, is deeply saddened by the tragic truck accident that occurred on March 26, 2024, at approximately 8:00 a.m. along U.S. Highway 380 in Frisco, TX.

Key Points:

COLLIN COUNTY, Texas, April 18, 2024 /PRNewswire/ -- Grossman Law Offices, with its principal office in Dallas, TX, is deeply saddened by the tragic truck accident that occurred on March 26, 2024, at approximately 8:00 a.m. along U.S. Highway 380 in Frisco, TX.
The incident resulted in the loss of 28-year-old Ruoyang He .
Officials indicate that, for reasons yet to be confirmed, the Mustang was rear-ended by an eastbound 18-wheeler with a flatbed trailer in tow.
Ruoyang He incurred reportedly critical injuries as a result of the wreck and was transported to a local medical facility for immediate treatment.

Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases

Retrieved on:

星期四, 三月 28, 2024

WORCESTER, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for difficult-to-treat cancers and rare genetic diseases, today announced its expansion into autoimmune diseases with MB-106, a personalized CD20-targeted, 3rd-generation autologous CAR T-cell therapy. MB-106 is being developed in a collaboration between Mustang and Fred Hutchinson Cancer Center (“Fred Hutch”). Mustang and Fred Hutch are in preliminary discussions to explore a potential Phase 1 investigator-sponsored clinical trial to evaluate MB-106 for the treatment of autoimmune diseases.

Key Points:

MB-106 is being developed in a collaboration between Mustang and Fred Hutchinson Cancer Center (“Fred Hutch”).
Mustang and Fred Hutch are in preliminary discussions to explore a potential Phase 1 investigator-sponsored clinical trial to evaluate MB-106 for the treatment of autoimmune diseases.
“MB-106’s observed safety profile, encouraging efficacy data, and our robust manufacturing capabilities have the potential to translate to improved outcomes for patients with autoimmune diseases.
Several antibody therapies targeting CD20 on B-cells have successfully transitioned from cancer to autoimmune diseases, such as rituximab for both lymphoma and rheumatoid arthritis.

G Force Performance Adds an Impressive Group of Products First Quarter 2024

Retrieved on:

星期二, 四月 9, 2024

WADSWORTH, Ohio, April 9, 2024 /PRNewswire-PRWeb/ -- G Force Performance Products, a trusted source of aftermarket automotive components, announced the addition of several notable products to its lineup for the first quarter of 2024.

Key Points:

G Force Performance Products, a trusted source for aftermarket automotive components, announced the addition of several notable products to its lineup for the first quarter of 2024.
WADSWORTH, Ohio, April 9, 2024 /PRNewswire-PRWeb/ -- G Force Performance Products , a trusted source of aftermarket automotive components, announced the addition of several notable products to its lineup for the first quarter of 2024.
G Force is constantly improving and adding to our product line to make upgrading car and truck performance faster, easier, and more satisfying for the enthusiast.
For more information, please visit G Force Performance Products' official website at crossmembers.com.

Automakers’ Record Number of EV Demos At Electrify Expo Indicates EV Demand is Hot

Retrieved on:

星期一, 三月 18, 2024

Mustang, Volvo, Lexus, EVS, Thrill, State Farm Stadium, Hare, Ford, Kia, BMW, Hankook Tire, Super Bowl, Super73

Rivian’s all-new R2 SUV was a major draw for attendees as the vehicle made its East Coast debut.

Key Points:

Rivian’s all-new R2 SUV was a major draw for attendees as the vehicle made its East Coast debut.
In addition, Kia and Volvo returned to the festival with some of their much anticipated EVs including Kia’s EV9 and Volvo’s EX30.
Ford returned to the Thrill Zone offering festival goers the opportunity to take a hot lap in the Mustang Mach-E® GT with a professional driver.
“The turnout in Orlando was massive and it's evidence that EV demand is growing fast,” said BJ Birtwell, CEO and founder of Electrify Expo.

TLF Performance Parts Proudly Presents Their Recent Inventory Expansion

Retrieved on:

星期二, 三月 19, 2024

Quality control, Mustang, TLF, Lexus, Toyota 86, GDI, F-150, Ford, Grand tourer, Toyota, Coup d'état, OEM, Camshaft, NX300

ELDORADO, Ill., March 19, 2024 /PRNewswire/ -- TLF Performance Parts is thrilled to announce the latest additions to their product lineup!

Key Points:

ELDORADO, Ill., March 19, 2024 /PRNewswire/ -- TLF Performance Parts is thrilled to announce the latest additions to their product lineup!
These high-quality parts are designed to enhance the performance and reliability of these popular vehicle models.
TLF Performance Parts offers a wide range of GDI fuel injectors, from stock OEM to high performance for high flow.
What sets TLF Performance Parts apart from their competitors is that they are the only company in the USA manufacturing high-performance fuel injectors for high-flow applications.

Mustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Retrieved on:

星期一, 三月 11, 2024

WORCESTER, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for difficult-to-treat cancers and rare genetic diseases, today announced financial results and recent corporate highlights for the full-year ended December 31, 2023.

Key Points:

WORCESTER, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for difficult-to-treat cancers and rare genetic diseases, today announced financial results and recent corporate highlights for the full-year ended December 31, 2023.
Research and development expenses were $40.5 million for the year ended December 31, 2023, compared to $62.5 million for 2022.
2023 and Recent Corporate Highlights:
In July 2023, Mustang announced that it amended its previously announced asset purchase agreement with uBriGene (Boston) Biosciences Inc. (“uBriGene”) and closed the transaction.
In October 2023, Mustang completed a registered direct offering priced at-the-market for approximately $4.4 million in gross proceeds.